Mercilon

Desogestrel/Ethinylestradiol, the active ingredients in Mercilon, are a combined oral contraceptive presented as tablets for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Mercilon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. With a focus on regulatory compliance, GNH USA ensures that each batch meets European pharmacopeia specifications and is delivered with appropriate documentation.

Mercilon, a combined oral contraceptive, acts on the hormonal regulation of the menstrual cycle to prevent pregnancy.

- Contraception: prevention of pregnancy in women of childbearing age - Menstrual cycle regulation: reduction of irregular bleeding and stabilization of cycle length - Acne management: improvement of acne lesions associated with hormonal fluctuations

Mercilon may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often occurring at treatment initiation - Headache: transient tension‑type headaches - Breast tenderness: temporary swelling or discomfort - Weight gain: slight increase in body weight - Mood changes: mild irritability or emotional fluctuations - Spotting: irregular uterine bleeding, especially during the first cycles

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs - Pulmonary embolism: blockage of pulmonary arteries - Stroke: cerebrovascular accident - Myocardial infarction: heart attack - Severe hypertension: sudden high blood pressure - Allergic reaction: rash, swelling, or anaphylaxis

Before prescribing Mercilon, healthcare professionals should consider several precautionary measures to ensure patient safety. - Smoking status: avoid use in women over 35 who smoke due to increased cardiovascular risk - Cardiovascular history: assess for hypertension, thromboembolic disorders, or coronary artery disease - Liver function: evaluate hepatic impairment as it may affect hormone metabolism - Medication history: review concurrent use of enzyme‑inducing drugs that may reduce efficacy - Pregnancy and lactation: contraindicated during pregnancy; advise breastfeeding women of potential risks - Store at ambient temperature: keep tablets below 25 °C in the original packaging, protected from moisture and light

Mercilon can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Antiepileptics (e.g., carbamazepine, phenytoin): significantly reduce hormone levels, compromising contraceptive efficacy - Rifampicin and other strong enzyme inducers: decrease plasma concentrations of both hormones - Certain HIV protease inhibitors: may increase hormone levels, raising risk of side effects - St. John’s wort: herbal inducer that lowers contraceptive effectiveness - Anticoagulants (e.g., warfarin): estrogen component may enhance anticoagulant effect, requiring monitoring

Moderate Interactions (Monitor Closely): - Antibiotics (e.g., tetracycline, metronidazole): may have modest impact on hormone levels - Antifungal agents (e.g., fluconazole): can increase estrogen exposure - Antidepressants (SSRIs): potential for altered hormone metabolism - Diuretics (e.g., thiazides): may affect fluid balance and blood pressure - Herbal supplements (e.g., ginseng): possible interaction affecting efficacy